• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测组织重塑酶的肽网络在肝细胞癌预后中的应用。

Peptide network for detection of tissue-remodeling enzyme in the prognosis of hepatocellular carcinoma.

机构信息

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School , Nanjing 210008, China.

出版信息

ACS Appl Mater Interfaces. 2015 Feb 25;7(7):4401-5. doi: 10.1021/am5089378. Epub 2015 Feb 10.

DOI:10.1021/am5089378
PMID:25629926
Abstract

In this work, a surface-confined peptide network that can exhibit distinct structural features under protease cleavage and electrochemical treatment is developed as a highly sensitive biosensor for clinical detection of kallikrein 6 (KLK6). KLK6 is a serine protease of the tissue-remodeling process determining the development of hepatocellular carcinoma (HCC). The peptide network, immobilized on the electrode surface by a Au-S bond, loses its integrity upon KLK6 cleavage and is removed from the electrode by electrochemical desorption of thiol groups, while the network without protease cleavage can remain attached by a few intact Au-S bonds. In this manner, distinct conductivity of the electrode surface in the presence/absence of protease can result in a large signal-to-background ratio, enabling KLK6 detection in clinical samples. The detected KLK6 abundance can manifest the correlation between up-regulated KLK6 activity and the progress of HCC. These results suggest a potential future use of this peptide network as a biosensor to provide diagnostic information for better administration of HCC.

摘要

在这项工作中,开发了一种表面限制的肽网络,该网络在蛋白酶切割和电化学处理下可以表现出明显的结构特征,可作为用于临床检测激肽释放酶 6(KLK6)的高灵敏度生物传感器。KLK6 是一种丝氨酸蛋白酶,参与组织重塑过程,决定了肝细胞癌(HCC)的发展。肽网络通过 Au-S 键固定在电极表面上,在 KLK6 切割时会失去完整性,并通过硫醇基团的电化学解吸从电极上除去,而没有蛋白酶切割的网络可以通过几个完整的 Au-S 键保持附着。通过这种方式,存在/不存在蛋白酶时电极表面的明显导电性会导致大的信号背景比,从而能够在临床样本中检测 KLK6。检测到的 KLK6 丰度可以表现出上调的 KLK6 活性与 HCC 进展之间的相关性。这些结果表明,这种肽网络作为生物传感器具有潜在的未来用途,可以为 HCC 的更好管理提供诊断信息。

相似文献

1
Peptide network for detection of tissue-remodeling enzyme in the prognosis of hepatocellular carcinoma.用于检测组织重塑酶的肽网络在肝细胞癌预后中的应用。
ACS Appl Mater Interfaces. 2015 Feb 25;7(7):4401-5. doi: 10.1021/am5089378. Epub 2015 Feb 10.
2
Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy.从肝硬化进展到癌症与早期泛素翻译后修饰有关:识别有恶性风险的肝硬化新生物标志物。
J Pathol. 2014 Dec;234(4):452-63. doi: 10.1002/path.4398. Epub 2014 Sep 12.
3
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.评估和预测结直肠癌中人组织激肽释放酶相关肽 6(KLK6)的意义。
Pathol Res Pract. 2012 Feb 15;208(2):104-8. doi: 10.1016/j.prp.2011.12.010. Epub 2012 Jan 28.
4
SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.SUOX 是一种有前途的肝细胞癌诊断和预后生物标志物。
J Hepatol. 2013 Sep;59(3):510-7. doi: 10.1016/j.jhep.2013.04.028. Epub 2013 May 9.
5
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能:与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
6
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.蛋氨酸腺苷转移酶失调的多效性作用作为肝癌进展和预后的决定因素。
J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7.
7
State-of-the-art Hepatocellular Carcinoma Biomarker Detection by Biosensor Technology-a Review.基于生物传感器技术的肝癌生物标志物检测的最新进展:综述
J Gastrointest Cancer. 2021 Sep;52(3):1081-1085. doi: 10.1007/s12029-021-00680-4. Epub 2021 Aug 4.
8
Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.基于切除的小肝细胞癌的蛋白质组分析,谷氨酰胺合成酶作为肝细胞癌的早期标志物。
Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):296-305.
9
Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.JWA 的下调促进了人肝癌细胞的侵袭,并预测了不良的预后。
Mol Carcinog. 2014 Apr;53(4):325-36. doi: 10.1002/mc.21981. Epub 2012 Nov 20.
10
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.人组织激肽释放酶相关肽酶6和10在早期胃食管腺癌中表达的评估
Hum Pathol. 2015 Apr;46(4):541-8. doi: 10.1016/j.humpath.2014.12.005. Epub 2014 Dec 31.

引用本文的文献

1
Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview.用于早期检测肝细胞癌特异性生物标志物的生物传感器技术的最新进展:综述
Diagnostics (Basel). 2024 Jul 15;14(14):1519. doi: 10.3390/diagnostics14141519.
2
Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma.尿肽在肝细胞癌中的病理生理意义
Cancers (Basel). 2021 Jul 27;13(15):3786. doi: 10.3390/cancers13153786.
3
Tissue-specific NETs alter genome organization and regulation even in a heterologous system.
组织特异性中性粒细胞胞外陷阱即使在异源系统中也会改变基因组组织和调控。
Nucleus. 2017 Jan 2;8(1):81-97. doi: 10.1080/19491034.2016.1261230. Epub 2017 Jan 3.